TY - JOUR
T1 - An integrative histopathologic clustering model based on immuno-matrix elements to predict the risk of death in malignant mesothelioma
AU - Balancin, Marcelo Luiz
AU - Teodoro, Walcy Rosolia
AU - Farhat, Cecilia
AU - de Miranda, Tomas Jurandir
AU - Assato, Aline Kawassaki
AU - de Souza Silva, Neila Aparecida
AU - Velosa, Ana Paula
AU - Falzoni, Roberto
AU - Ab'Saber, Alexandre Muxfeldt
AU - Roden, Anja C.
AU - Capelozzi, Vera Luiza
N1 - Funding Information:
The research reported in this publication was supported in part by the Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP, Brazil) (2018/20403‐6) and the Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq, Brazil) 483005/2012‐6. The SP263 antibody kit was received as a research grant from Roche Diagnostics (Roche‐Ventana, Tucson, USA).
Publisher Copyright:
© 2020 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
PY - 2020/7/1
Y1 - 2020/7/1
N2 - Objective: Previous studies have reported a close relationship between malignant mesothelioma (MM) and the immune matricial microenvironment (IMM). One of the major problems in these studies is the lack of adequate adjustment for potential confounders. Therefore, the aim of this study was to identify and quantify risk factors such as IMM and various tumor characteristics and their association with the subtype of MM and survival. Methods: We examined IMM and other tumor markers in tumor tissues from 82 patients with MM. These markers were evaluated by histochemistry, immunohistochemistry, immunofluorescence, and morphometry. Logistic regression analysis, cluster analysis, and Cox regression analysis were performed. Results: Hierarchical cluster analysis revealed two clusters of MM that were independent of clinicopathologic features. The high-risk cluster included MM with high tumor cellularity, high type V collagen (Col V) fiber density, and low CD8+ T lymphocyte density in the IMM. Our results showed that the risk of death was increased for patients with MM with high tumor cellularity (OR = 1.63, 95% CI = 1.29-2.89, P =.02), overexpression of Col V (OR = 2.60, 95% CI = 0.98-6.84, P =.04), and decreased CD8 T lymphocytes (OR = 1.001, 95% CI = 0.995-1.007, P =.008). The hazard ratio for the high-risk cluster was 2.19 (95% CI = 0.54-3.03, P <.01) for mortality from MM at 40 months. Conclusion: Morphometric analysis of Col V, CD8+ T lymphocytes, and tumor cellularity can be used to identify patients with high risk of death from MM.
AB - Objective: Previous studies have reported a close relationship between malignant mesothelioma (MM) and the immune matricial microenvironment (IMM). One of the major problems in these studies is the lack of adequate adjustment for potential confounders. Therefore, the aim of this study was to identify and quantify risk factors such as IMM and various tumor characteristics and their association with the subtype of MM and survival. Methods: We examined IMM and other tumor markers in tumor tissues from 82 patients with MM. These markers were evaluated by histochemistry, immunohistochemistry, immunofluorescence, and morphometry. Logistic regression analysis, cluster analysis, and Cox regression analysis were performed. Results: Hierarchical cluster analysis revealed two clusters of MM that were independent of clinicopathologic features. The high-risk cluster included MM with high tumor cellularity, high type V collagen (Col V) fiber density, and low CD8+ T lymphocyte density in the IMM. Our results showed that the risk of death was increased for patients with MM with high tumor cellularity (OR = 1.63, 95% CI = 1.29-2.89, P =.02), overexpression of Col V (OR = 2.60, 95% CI = 0.98-6.84, P =.04), and decreased CD8 T lymphocytes (OR = 1.001, 95% CI = 0.995-1.007, P =.008). The hazard ratio for the high-risk cluster was 2.19 (95% CI = 0.54-3.03, P <.01) for mortality from MM at 40 months. Conclusion: Morphometric analysis of Col V, CD8+ T lymphocytes, and tumor cellularity can be used to identify patients with high risk of death from MM.
KW - biomarkers
KW - cluster analysis
KW - collagen type V
KW - computational pathology
KW - extracellular matrix
KW - immunomodulation
KW - mesothelioma
UR - http://www.scopus.com/inward/record.url?scp=85084487536&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85084487536&partnerID=8YFLogxK
U2 - 10.1002/cam4.3111
DO - 10.1002/cam4.3111
M3 - Article
C2 - 32391978
AN - SCOPUS:85084487536
SN - 2045-7634
VL - 9
SP - 4836
EP - 4849
JO - Cancer Medicine
JF - Cancer Medicine
IS - 13
ER -